Ledger.Open graph →

SEC Form D · filed August 7, 2015

Gemphire Therapeutics Inc

Offering

$3.0M

Sold

$2.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NORTHVILLE, MI

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

David Lowenschuss · Northville, MIExec · Director Mina Sooch · Northville, MIExec · Director Margaret Mcshane · Northville, MIExec Kenneth Kousky · Midland, MIDirector Andy Sassine · Rancho Santa Fe, CADirector Charles Bisgaier · Northville, MIExec · Director Daniela Oniciu · Northville, MIExec P. K. Hawryluk · Carmel, INDirector William Alaynick · San Diego, CAExec · Director Vanessa Barrett · Grand Cayman, Cayman IslandsDirector Paul Nasser · BOSTON, MADirector Deborah L. Machovec · Wahoo, NEDirector Amir Belson · Menlo Park, CAExec · Director Kenneth Hood · San Diego, CAExec · Director Lawrence Chavez · Albuquerque, NMExec Hurley Doddy · George Town, Grand Cayman, Cayman IslandsDirector Marc A. Weiser · Ann Arbor, MIExec · Director Pravin V. Gandhi · Fort Mumbai, K7Exec · Director Bala V. Deshpande · Timonium, MDExec · Director George A. Parris · Audubon, IAExec · Director Jon Cheek · SAN FRANCISCO, CAExec Jt Michelson · Albuquerque, NMExec Alan I. Bossin · Hamilton, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗